Assessment of GCC pharmaceutical market for a global European pharma major

  • Analysed potential for entry into the GCC pharmaceutical market

  • Helped client understand socio-economic and health policies in GCC countries

  • A global European pharma major wanted to assess the market’s viability as an investment opportunity
  • Key challenges were :
    • Scarcity of data in GCC countries
    • Highly fragmented pharmaceutical markets in GCC countries
    • The need to understand socio-economic determinants and government policies
  • Market assessment :
    • Estimated market size using the bottom-up approach
    • Assessed market dynamics, drivers and barrier to entry
    • Assessed the top players in market, their revenue streams and plans
    • Assessed sub-sectors based on competition
  • Socio-economic determinants :
    • Tracked spending as a percentage of GDP on the healthcare sector and per capita expenditure on healthcare
    • Gained an understanding of the proportion of the aged population and incidence of chronic disease
    • Analysed participation of private hospitals and health insurance
  • Government/health policies :
    • Tracked healthcare-related policies
    • Tracked regulatory, pricing and reimbursement policies
    • Gained an understanding of government policies in terms of setting up manufacturing bases and foreign investments
  • Advised on sub-sectors with unmet need and market attractiveness
  • Assessed possible market drivers and barriers to entry
Thank you for sharing your details

Your file will start downloading automatically

If it does not download within 1 minute,

Share this on

What we have done

Competitor benchmarking and performance gap analysis for a leading European medical device player
What we are proud of

Identified opportunities for expansion and plausible revenue streams

Identified potential geographies and activation levers from competitors

Opportunity assessment and market attractiveness for one of the top 10 pharmaceutical major
What we are proud of

Benchmarked therapeutic areas with high clinical and market potential

Developed potential market scenarios based on client needs

Assessing viability of entering the NSCLC market
What we are proud of

Evaluated unmet needs to identify potential entry points

Conducted a deep-dive study of key assets and key players

Supplier assessment and industry benchmarking for a global top 10 pharmaceutical company
What we are proud of

Optimised vendor-associated costs across geographies

Identified billing arrangements across law firms